The Assisted Reproductive Technology Market size to grow at a CAGR of 5.79% from 2022 to 2027|The increase in awareness of ART to boost the market growth- Technavio

NEW YORK, Aug. 4, 2023 /PRNewswire/ -- The assisted reproductive technology market is expected to grow by USD 8,232.63 million during 2023-2027, progressing at a CAGR of 5.79% as per the latest Technavio market research report. Europe is going to have lucrative growth during the forecast period. About 32% of the market's overall growth is expected to originate from Europe. The increasing elderly population facing infertility issues, particularly due to declining egg quality in women, is a significant factor driving the demand for assisted reproductive technology (ART) in Europe. Countries like Italy, the UK, Germany, France, and Spain are key contributors to this trend. Additionally, favorable reimbursement policies and the availability of advanced ART techniques further support the growth of the fertility treatment market in the region. Hence, these factors are expected to drive segment growth in the market during the forecast period. For more insights on the market share of various regions- Download a sample report in MINUTES

Why Buy?

• Add credibility to the strategy.
• Analyzes competitor's offerings. 
• Get a holistic view of the market.
• Grow your profit margin with Technavio- Buy the Report

Assisted Reproductive Technology Market: Market Dynamics

Key Drivers

The growing awareness of ART is a key factor driving the growth of the market. The increasing use of assisted reproductive technology (ART) can be attributed to several important factors, including changing public perceptions, increasing infertility rates, and advances in ART technology. As awareness of the benefits of ART has grown, barriers have been removed, and social stigma has decreased fertility treatment has become more accessible to individuals and couples. Therefore, these factors are expected to drive market growth during the forecast period.

Major Trends

The increasing number of single-parent families is a major trend in the market. The increasing acceptance of single-parent families and rising divorce rates have led to a significant increase in the use of fertility clinics by single women around the world. Counseling and other initiatives have helped the single parent overcome obstacles such as finances and stress and facilitated access to health insurance and choice of ART procedures to build a family. Hence, these factors are expected to drive market growth during the forecast period.

Significant Challenges

The side effects of infertility treatment are a significant challenge restricting the market growth. As the use of assisted reproductive technology increases, there is growing concern about potential side effects on the patient's overall health. Women undergoing IVF and related treatments may experience stress, complications, and risk of multiple pregnancies. Additionally, these procedures can cause side effects such as nausea, vomiting, shortness of breath, and severe abdominal pain after procedures. Hence, side effects are expected to restrict market growth during the forecast period.

To know about more drivers, trends along with challenges - Download a sample now!

Some of the key Assisted Reproductive Technology Market Players:

The assisted reproductive technology market is fragmented, and companies are deploying organic and inorganic growth strategies to compete in the market.

Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp., Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd.

Assisted Reproductive Technology Market: Segmentation Analysis

This market research report segments the assisted reproductive technology market by application (fertility clinics, hospitals, and others), type (IVF and artificial insemination), and geography (Europe, North America, Asia, and the Rest of the World (ROW)).

• The fertility clinics segment is estimated to witness significant growth during the forecast period. The growth of the fertility clinics segment is being driven by factors like the increased number of fertility centers to meet the unmet demand and the rising number of fertility patients seeking treatment. Hence, the success of such fertility clinics is expected to drive segment growth in the market during the forecast period.

For additional information on the market contribution of each segment - Grab an Exclusive Sample Report

Company Landscape

• Companies covered.
• Company classification
• Market positioning of companies
• Competitive scenario

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports

The Duchenne muscular dystrophy (DMD) therapeutics market is estimated to grow by USD 2,397.67 million at a CAGR of 21.2% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by type (biologics and small molecules), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The high unmet need among patients with Duchenne muscular dystrophy (DMD) is a key factor driving market growth during the forecast period.

The photodynamic therapy market is estimated to grow by USD 2,053.68 million at a CAGR of 8.22% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (cancer, actinic keratosis, psoriasis, acne, and others), product (photosensitizer drugs, and photodynamic therapy devices), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Early detection of cancer is a key factor driving market growth during the forecast period.

Table of Contents

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market Definition
• Exhibit 12: Offerings of companies included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global assisted reproductive technology market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global assisted reproductive technology market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Type Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Fertility clinics - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Fertility clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Fertility clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Fertility clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Fertility clinics - Year-over-year growth 2022-2027 (%)

• 6.4 Hospitals - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 6.5 Others - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Application 
• Exhibit 46: Market opportunity by Application ($ million)
• Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type

• 7.3 IVF - Market size and forecast 2022-2027 
• Exhibit 52: Chart on IVF - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on IVF - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on IVF - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on IVF - Year-over-year growth 2022-2027 (%)

• 7.4 Artificial insemination - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Artificial insemination - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Artificial insemination - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Artificial insemination - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Artificial insemination - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 60: Market opportunity by Type ($ million)
• Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 63: Chart on Market share by geography 2022-2027 (%)
• Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison

• 9.3 Europe - Market size and forecast 2022-2027 
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.4 North America - Market size and forecast 2022-2027 
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027 
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027 
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 Germany - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 103: Market opportunity by geography ($ million)
• Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Company Landscape

• 11.1 Overview

• 11.2 Company Landscape 
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Company Analysis

• 12.1 Companies covered 
• Exhibit 109: Companies covered

• 12.2 Market positioning of companies
• Exhibit 110: Matrix on company position and classification

• 12.3 Cook Group Inc.
• Exhibit 111: Cook Group Inc. - Overview
• Exhibit 112: Cook Group Inc. - Product / Service
• Exhibit 113: Cook Group Inc. - Key offerings

• 12.4 CRITEX GmbH
• Exhibit 114: CRITEX GmbH - Overview
• Exhibit 115: CRITEX GmbH - Product / Service
• Exhibit 116: CRITEX GmbH - Key offerings

• 12.5 Cryolab Ltd.
• Exhibit 117: Cryolab Ltd. - Overview
• Exhibit 118: Cryolab Ltd. - Product / Service
• Exhibit 119: Cryolab Ltd. - Key offerings

• 12.6 Esco Micro Pte. Ltd.
• Exhibit 120: Esco Micro Pte. Ltd. - Overview
• Exhibit 121: Esco Micro Pte. Ltd. - Product / Service
• Exhibit 122: Esco Micro Pte. Ltd. - Key offerings

• 12.7 Ferring BV
• Exhibit 123: Ferring BV - Overview
• Exhibit 124: Ferring BV - Product / Service
• Exhibit 125: Ferring BV - Key offerings

• 12.8 FUJIFILM Holdings Corp. 
• Exhibit 126: FUJIFILM Holdings Corp. - Overview
• Exhibit 127: FUJIFILM Holdings Corp. - Business segments
• Exhibit 128: FUJIFILM Holdings Corp. - Key offerings
• Exhibit 129: FUJIFILM Holdings Corp. - Segment focus

• 12.9 Genea Ltd.
• Exhibit 130: Genea Ltd. - Overview
• Exhibit 131: Genea Ltd. - Product / Service
• Exhibit 132: Genea Ltd. - Key offerings

• 12.10 IMV Technologies
• Exhibit 133: IMV Technologies - Overview
• Exhibit 134: IMV Technologies - Product / Service
• Exhibit 135: IMV Technologies - Key offerings

• 12.11 Instituto Bernabeu SL 
• Exhibit 136: Instituto Bernabeu SL - Overview
• Exhibit 137: Instituto Bernabeu SL - Product / Service
• Exhibit 138: Instituto Bernabeu SL - Key offerings

• 12.12 INVO Bioscience Inc.
• Exhibit 139: INVO Bioscience Inc. - Overview
• Exhibit 140: INVO Bioscience Inc. - Product / Service
• Exhibit 141: INVO Bioscience Inc. - Key offerings

• 12.13 Merck KGaA
• Exhibit 142: Merck KGaA - Overview
• Exhibit 143: Merck KGaA - Business segments
• Exhibit 144: Merck KGaA - Key news
• Exhibit 145: Merck KGaA - Key offerings
• Exhibit 146: Merck KGaA - Segment focus

• 12.14 Monash IVF Group Ltd. 
• Exhibit 147: Monash IVF Group Ltd. - Overview
• Exhibit 148: Monash IVF Group Ltd. - Business segments
• Exhibit 149: Monash IVF Group Ltd. - Key offerings
• Exhibit 150: Monash IVF Group Ltd. - Segment focus

• 12.15 The Cooper Companies Inc. 
• Exhibit 151: The Cooper Companies Inc. - Overview
• Exhibit 152: The Cooper Companies Inc. - Business segments
• Exhibit 153: The Cooper Companies Inc. - Key offerings
• Exhibit 154: The Cooper Companies Inc. - Segment focus

• 12.16 Virtus Health
• Exhibit 155: Virtus Health - Overview
• Exhibit 156: Virtus Health - Business segments
• Exhibit 157: Virtus Health - Key news
• Exhibit 158: Virtus Health - Key offerings
• Exhibit 159: Virtus Health - Segment focus

• 12.17 Vitrolife AB
• Exhibit 160: Vitrolife AB - Overview
• Exhibit 161: Vitrolife AB - Business segments
• Exhibit 162: Vitrolife AB - Key offerings
• Exhibit 163: Vitrolife AB - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 166: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources

• 13.5 List of abbreviations
• Exhibit 170: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Infiniti Research, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED